Literature DB >> 3022792

Target-sensitive immunoliposomes: preparation and characterization.

R J Ho, B T Rouse, L Huang.   

Abstract

A novel target-sensitive immunoliposome was prepared and characterized. In this design, target-specific binding of antibody-coated liposomes was sufficient to induce bilayer destabilization, resulting in a site-specific release of liposome contents. Unilamellar liposomes were prepared by using a small quantity of palmitoyl-immunoglobulin G (pIgG) to stabilize the bilayer phase of the unsaturated dioleoylphosphatidylethanolamine (PE) which by itself does not form stable liposomes. A mouse monoclonal IgG antibody to the glycoprotein D of Herpes simplex virus (HSV) and PE were used in this study. A minimal coupling stoichiometry of 2.2 palmitic acids per IgG was essential for the stabilization activity of pIgG. In addition, the minimal pIgG to PE molar ratio for stable liposomes was 2.5 X 10(-4). PE immunoliposomes bound with HSV-infected mouse L929 cells with an apparent Kd of 1.00 X 10(-8) M which was approximately the same as that of the native antibody. When 50 mM calcein was encapsulated in the PE immunoliposomes as an aqueous marker, binding of the liposomes to HSV-infected cells resulted in a cell concentration dependent lysis of the liposomes as detected by the release of the encapsulated calcein. Neither uninfected nor Sendai virus infected cells caused a significant amount of calcein release. Therefore, the release of calcein from PE immunoliposomes was target specific. Dioleoylphosphatidylcholine immunoliposomes were not lysed upon contact with infected cells under the same conditions, indicating that PE was essential for the target-specific liposome destabilization.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3022792     DOI: 10.1021/bi00367a023

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

Review 1.  Biodegradable nanoparticles for cytosolic delivery of therapeutics.

Authors:  Jaspreet K Vasir; Vinod Labhasetwar
Journal:  Adv Drug Deliv Rev       Date:  2007-06-26       Impact factor: 15.470

2.  Cholera toxin B-mediated targeting of lipid vesicles containing ganglioside GM1 to mucosal epithelial cells.

Authors:  T Lian; R J Ho
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

Review 3.  Membrane adhesion and the formation of heterogeneities: biology, biophysics, and biotechnology.

Authors:  V D Gordon; T J O'Halloran; O Shindell
Journal:  Phys Chem Chem Phys       Date:  2015-04-13       Impact factor: 3.676

Review 4.  Controlling subcellular delivery to optimize therapeutic effect.

Authors:  Mohanad Mossalam; Andrew S Dixon; Carol S Lim
Journal:  Ther Deliv       Date:  2010-07

5.  Lipid composition is important for highly efficient target binding and retention of immunoliposomes.

Authors:  K Maruyama; S J Kennel; L Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

6.  Fibrinogen-mimicking, multiarm nanovesicles for human thrombus-specific delivery of tissue plasminogen activator and targeted thrombolytic therapy.

Authors:  Yu Huang; Boram Gu; Isabelle I Salles-Crawley; Kirk A Taylor; Li Yu; Jie Ren; Xuhan Liu; Michael Emerson; Colin Longstaff; Alun D Hughes; Simon A Thom; Xiao Yun Xu; Rongjun Chen
Journal:  Sci Adv       Date:  2021-06-02       Impact factor: 14.136

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.